296 Folgen

The Green Rush is real. From lawmakers and investment bankers, to CEOs and investors, we will look at how people are transforming cannabis from the shadows of the illicit market into a cash crop that draws in entrepreneurs from Hollywood to Wall Street. Hosts Lewis Goldberg and Anne Donohoe help you navigate the business of cannabis.

The Green Rush is real‪.‬ The Green Rush is real.

    • Nachrichten

The Green Rush is real. From lawmakers and investment bankers, to CEOs and investors, we will look at how people are transforming cannabis from the shadows of the illicit market into a cash crop that draws in entrepreneurs from Hollywood to Wall Street. Hosts Lewis Goldberg and Anne Donohoe help you navigate the business of cannabis.

    Paul Armentano, Deputy Director of NORML

    Paul Armentano, Deputy Director of NORML

    Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.



    This week Anne Donohoe and Kris Krane are back to sit down with Paul Armentano, Deputy Director of NORML. Paul joined our hosts this week to talk about his career of advocacy work within the cannabis space and to highlight the positives and shortcomings with the DEA’s proposed move to reschedule cannabis. Paul walked us through his thoughts, which can also be found in his recent op-ed in the Orange County Register, as well as what he thinks will move the needle through the DEA open comment period. 



    Kris and Paul also dive into the debate of incrementalism vs full reform for cannabis as well as why it’s critical to ensure advocacy organizations like NORML stay funded and operational, even as the U.S. becomes more accepting of cannabis.  



    If you are interested in learning more about Paul or how to get more involved in NORML’s work, visit the links in our show notes. Also, be sure to follow NORML, as well as the organization’s local chapters, across all social platforms.



    So, sit back and enjoy our conversation with Paul Armentano of NORML.



    Links, mentions, and socials:



    NORML Website: https://norml.org/marijuana 

    NORML Instagram: https://www.instagram.com/natlnorml 

    NORML News: https://norml.org/subscribe 

    Paul’s Appearance on The Disagreement: https://thedisagreement.substack.com/p/episode-7-marijuana-legalization

    Paul’s review on scientific literature around cannabis and cannabinoids: https://www.amazon.com/Clinical-Applications-Cannabis-Cannabinoids-Scientific-ebook/dp/B09KSTZPDJ

    NORML on recent medical marijuana research: https://norml.org/marijuana/library/recent-medical-marijuana-research/

    Recent bylines from Paul: https://otherwords.org/authors/paul-armentano/ 

    Paul’s OC Register byline: https://www.ocregister.com/2024/05/14/the-beginning-of-the-end-of-cannabis-prohibition/ 



    Show Credits:



    This episode was hosted by Anne Donohoe and Kris Krane of KCSA Strategic Communications. 



    Special thanks to our Program Director Shea Gunther.



    You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:



    X: @The_GreenRush



    Instagram: @thegreenrush_podcast



    LinkedIn: linkedin.com/company/thegreenrushpodcast



    Facebook: facebook.com/TheGreenRushPodcast 



    YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

    • 1 Std. 3 Min.
    Revisiting Our Conversation with Dr. Hans Eriksson, Chief Medical Officer for HMNC Brain Health

    Revisiting Our Conversation with Dr. Hans Eriksson, Chief Medical Officer for HMNC Brain Health

    Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.



    This week we wanted to revisit our conversation with special guest Dr. Hans Eriksson, Chief Medical Officer for HMNC Brain Health. Hans joined us to discuss his role at HMNC, the company’s research and development efforts to identify and bring to market treatments for mental health disorders, and the latest news and progress on the psychedelics movement.



    With the death of the beloved actor Matthew Perry back in the news, we spoke with Hans about illicit ketamine use and how the news about Perry’s use was presented by the media, and the risks associated with the treatment.



    If you are interested in learning more about Hans or to check out the latest updates from HMNC Brain Health, visit the links in our show notes. Also, be sure to follow HMNC and Hans on LinkedIn.



    So, sit back and enjoy our conversation with Dr. Hans Eriksson of HMNC Brain Health.



    Links, mentions, and socials:



    HMNC Brain Health: hmnc-brainhealth.com

    HMNC Brain Health LinkedIn: de.linkedin.com/company/hmnc-brain-health

    Dr. Hans Eriksson LinkedIn: linkedin.com/in/hansaeriksson

    https://www.washingtonpost.com/entertainment/2024/05/22/matthew-perry-death-investigation-ketamine/ 



    Show Credits:



    This episode was hosted by Nick Opich and Anne Donohoe of KCSA Strategic Communications. 



    Special thanks to our Program Director Shea Gunther.



    You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:



    X: @KCSAPodcastLabs



    Instagram: @KCSAPodcastLabs



    LinkedIn: linkedin.com/company/thegreenrushpodcast

    • 30 Min.
    MAPS Roundtable on DEA Rescheduling of Cannabis

    MAPS Roundtable on DEA Rescheduling of Cannabis

    Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture.



    This week’s episode is a crossover roundtable event with our friends at the Multidisciplinary Association for Psychedelic Studies (MAPS) covering the DEA’s proposed rescheduling of cannabis from Schedule I to a Schedule III drug. Hosted by our very own Anne Donohoe, the Q&A discussion also features Betty Aldworth, Director of Communications & Post-Prohibition Strategy at MAPS, Karen O’Keefe, Director of State Policies at Marijuana Policy Project (MPP) and Paul Armentano, Deputy Director at NORML. 



    With the unprecedented federal drug policy change on the near horizon, MAPS assembled leaders with more than 50 years of combined experience in the cannabis policy reform movement to talk about what these changes are, why they matter, what myths need debunking, and what still needs to be done. Some of the topics covered in this conversation include the impact rescheduling will have on research and development of cannabis-based medicines, criminal law and systems-impacted people, cannabis banking and interstate commerce and veteran affairs. 



    If you are interested in learning more about how MAPS, MPP or NORML have played pivotal roles in implementing drug policy reform over the decades, be sure to follow them all on their socials linked in our show notes and visit their websites to follow their advocacy work.  



    So, sit back and enjoy this crossover Q&A discussion on the future of cannabis drug policy. 



    Links and mentions in the show



    https://maps.org/ 

    https://norml.org/ 

    https://www.mpp.org/ 



    Links to the guest’s company and social media accounts



    Betty Aldworth LinkedIn: https://www.linkedin.com/in/bettyaldworth/ 

    Karen O’Keefe LinkedIn: https://www.linkedin.com/in/karen-o-keefe-255a9921a/ 

    NORML LinkedIn: https://www.linkedin.com/company/norml/ 

    MPP Twitter: https://twitter.com/marijuanapolicy 

    NORML Twitter: https://twitter.com/NORML 

    MAPS Twitter: https://twitter.com/maps 



    Show Credits:



    This episode was hosted by Anne Donohoe of KCSA Strategic Communications.



    Special thanks to our Program Director, Shea Gunther and to the MAPS team. 



    You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:



    X: @KCSAPodcastLabs



    Instagram: @KCSAPodcastLabs



    LinkedIn: linkedin.com/company/thegreenrushpodcast

    • 52 Min.
    Adam Smith, Founder of Alliance for Sensible Markets

    Adam Smith, Founder of Alliance for Sensible Markets

    Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture. 



    This week Lewis Goldberg and Kris Krane sit down with long-time friend of the podcast Adam Smith, Founder and President of the Alliance for Sensible Markets, to talk about the DEA’s historic decision to reclassify cannabis from a Schedule I to Schedule III drug. As a long-time advocate working behind the scenes for decades to reverse the US’s draconian cannabis laws, Adam is cautiously optimistic about this development, noting that one of the most exciting changes will be the increase in research opportunities of cannabis for medical use.



    Adam and our hosts also discuss the potential impacts this development will have on the industry and markets, the elimination of the 280E tax, and the potential global rescheduling of cannabis under the UN Single Convention on Narcotics. As the industry awaits what comes next, the team identifies M&A opportunities and clarity on interstate commerce as key areas of interest to watch over the coming months. 



    If you are interested in learning more about Adam and how his organization is fighting for a more sustainable legal cannabis industry, visit the links in our show notes and be sure to follow Adam and the Alliance for Sensible Markets on LinkedIn.



    So, sit back and enjoy our conversation with Adam Smith, Founder of Alliance for Sensible Markets. 



    Links and mentions in the show



    https://www.sensiblemarkets.org/ 



    Links to the guest’s company and social media accounts



    Adam Smith LinkedIn: https://www.linkedin.com/in/thatadamsmith/ 

    Alliance for Sensible Markets Twitter: https://twitter.com/statescantwait 



    Show Credits:



    This episode was hosted by Lewis Goldberg and Kris Krane of KCSA Strategic Communications.



    Special thanks to our Program Director, Shea Gunther.



    You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:



    X: @KCSAPodcastLabs



    Instagram: @KCSAPodcastLabs



    LinkedIn: linkedin.com/company/thegreenrushpodcast

    • 56 Min.
    Ian Dominguez, Founder & CIO, Delta Emerald Ventures

    Ian Dominguez, Founder & CIO, Delta Emerald Ventures

    Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture. 



    This week hosts Anne and Phil speak with Ian Dominguez, founder and CIO of Delta Emerald Ventures, a leader in intelligent cannabis investing and industry insight. Ian joins Anne and Phil to talk about the booming market in hemp-derived products, including the growing drinks category, industry consolidation, and the conditions that lead him to start up CannaDataCon, a conference focusing on the intersection of legal cannabis and good data strategy.



    Links, mentions, and socials:



    Delta Emerald Ventures: https://www.deltaemerald.com/

    Ian Dominguez on LinkedIn: https://www.linkedin.com/in/iancdominguez/

    CannaDataCon: https://www.cannadatacon.com/

    CannaDataCon on LinkedIn: https://www.linkedin.com/company/88961565

    CannaDataCon on YouTube: https://www.youtube.com/channel/UCrkQ85bVUImGUrY3ZXIJFhg



    To learn more about CannaDataCon, check out Ian’s welcome remarks. And to go deeper into hemp beverages, check out Delta Emerald’s view on the category and hear how leading brands describe the regulatory environment.

     



    Show Credits:



    This episode was hosted by Phil Carlson and Anne Donohoe of KCSA Strategic Communications.



    Special thanks to our Program Director Shea Gunther.



    You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:



    Twitter: @KCSAPodcastLabs



    Instagram: @KCSAPodcastLabs



    LinkedIn: linkedin.com/company/thegreenrushpodcast

    • 42 Min.
    Revisiting Ric Flair, Hall-of-Fame Wrestler & Founder of Ric Flair Drip

    Revisiting Ric Flair, Hall-of-Fame Wrestler & Founder of Ric Flair Drip

    Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

    This week Lewis Goldberg is back for a revisited episode with special guest Ric Flair, Hall-of-Fame wrestler and Founder of Ric Flair Drip, a cannabis brand that offers flower, pre-rolls, edibles and more. Ric joins us this week to discuss his wrestling experiences and perspective on the industry, the parallels of wrestling and cannabis, and his product line Ric Flair Drip, plus a few special questions from fans.



    If you are interested in learning more about Ric Flair Drip, head to the links in our show notes. Also, be sure to follow Ric Flair and Ric Flair Drip on Instagram and Twitter to see what he’s up to and to learn more about his great products.



    So sit back and enjoy our conversation with the Nature Boy, himself. 



    Links and mentions in the show



    https://ricflairdrip.com/ 

    https://www.natureboyricflair.com/ 

    https://carmahold.com/ 



    Links to the guest’s company and social media accounts



    Ric Flair Drip Instagram: https://www.instagram.com/ricflairdrip/ 

    Ric Flair Drip Twitter: https://twitter.com/_RicFlairDrip 

    Ric Flair’s Instagram: https://www.instagram.com/ricflairnatureboy/ 

    Ric Flair’s Twitter: https://twitter.com/RicFlairNatrBoy 



    Show Credits:



    This episode was hosted by Lewis Goldberg of KCSA Strategic Communications. 



    Special thanks to our Program Director Shea Gunther.



    You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:



    Twitter: @The_GreenRush 



    Instagram: @thegreenrush_podcast



    LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/ 



    Facebook: https://www.facebook.com/TheGreenRushPodcast/ 



    YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

    • 40 Min.

Top‑Podcasts in Nachrichten

Echo der Zeit
Schweizer Radio und Fernsehen (SRF)
Apropos – der tägliche Podcast des Tages-Anzeigers
Tamedia
News Plus
Schweizer Radio und Fernsehen (SRF)
NZZ Akzent
NZZ – täglich ein Stück Welt
Servus. Grüezi. Hallo.
ZEIT ONLINE
15 Minuten. Der tagesschau-Podcast am Morgen
tagesschau

Das gefällt dir vielleicht auch

High-Rise: Cannabis MSOs, Products & Market Analysis
Headset, Inc.
Cannabis Insider
Benzinga
Weed Wonks
A Rootwurks and Strategies 64 Production
Cannabis Investing Network
CIN Podcast
The Cannabis Investing Podcast
Seeking Alpha
Higher Exchanges
Water Tower Research